All CMR exams were performed before doxorubicin administration, using a 3 Tesla Philips Achieva Tx whole-body scanner (Philips Healthcare, Best, the Netherlands) equipped with a 32-element phased-array cardiac coil. Imaging studies were performed under the same anaesthesia used for doxorubicin administration. Cardiac quantitative perfusion was estimated using dynamic acquisition with dual-saturation recovery (TS=20, 80 ms) during gadolinium-based contrast administration (0.1 mmol/kg), as previously described.12 (link) After perfusion map generation, regions of interest were analysed in the infused and remote areas using dedicated software (MR Extended Work Space 2.6, Philips Healthcare).
Free full text: Click here